Why the study?
Does NCOA6 dysfunction lead to dilated cardiomyopathy?
Does NCOA6 dysfunction lead to dilated cardiomyopathy?
NCOA6 dysfunction leads to dilated cardiomyopathy in mouse models and is associated with idiopathic DCM in humans, suggesting a novel genetic basis for the disease.
Answers are grounded in this paper and cite their sources.
NCOA6 dysfunction may contribute to idiopathic DCM; hypothesis-generating and requires validation in larger cohorts before any clinical application.
Dilated cardiomyopathy (DCM) is a progressive heart disease characterized by left ventricular dilation and contractile dysfunction. Although many candidate genes have been identified with mouse models, few of them have been shown to be associated with DCM in humans. Germline depletion of Ncoa6, a nuclear hormone receptor coactivator, leads to embryonic lethality and heart defects. However, it is unclear whether Ncoa6 mutations cause heart diseases in adults. Here, we report that two independent mouse models of NCOA6 dysfunction develop severe DCM with impaired mitochondrial function and reduced activity of peroxisome proliferator-activated receptor δ (PPARδ), an NCOA6 target critical for normal heart function. Sequencing of NCOA6-coding regions revealed three independent nonsynonymous mutations present in 5 of 50 (10%) patients with idiopathic DCM (iDCM). These data suggest that malfunction of NCOA6 can cause DCM in humans.
No takes yet. Share an insight, caveat, or question.
Roh et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: